Search
Search Results
##search.searchResults.foundPlural##
-
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1572PDF: 795HTML: 1491Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 183 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1578PDF: 772HTML: 2153Untitled: 228Untitled: 200Untitled: 197Untitled: 208Untitled: 202 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4805PDF: 1574HTML: 2251Untitled: 220Untitled: 237Untitled: 240Untitled: 224Untitled: 229 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2154PDF: 1332HTML: 3506 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
910PDF: 699HTML: 326 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1815PDF: 715HTML: 407 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1745PDF: 1455HTML: 254 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3339PDF: 1260HTML: 2210 -
BONE MARROW ABONRMALITIES IN HIV INFECTION
1908PDF: 1148HTML: 1767 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1606PDF: 627HTML: 224 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2782PDF: 980HTML: 4710 -
PREVALENCE OF ANEMIA, IRON DEFICIENCY, AND IRON DEFICIENCY ANEMIA AND DIAGNOSTIC PERFORMANCE OF HEMATOLOGIC AND BIOCHEMICAL MARKERS OF SIDEROPENIA IN 1- TO 5-YEAR-OLD CHILDREN IN THRACE GREECE Prevalence of ID, IDA and anemia in Greek Thrace
2019PDF: 859HTML: 286 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2250PDF: 824HTML: 1638Figure 1: 196Table 1: 217 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
896PDF: 502HTML: 157Suppl. Files: 331 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
981PDF: 1220HTML: 115 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1640PDF: 520HTML: 166 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
92PDF: 89HTML: 6 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2006PDF: 736HTML: 689Table1: patient's characteristics: 160Table 2: profile of each patient: 184 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1360HTML: 328PDF: 958Suppl. Files: 470 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
866PDF: 490HTML: 1310 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4306PDF: 1535HTML: 460 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4850PDF: 1826HTML: 2165 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12423PDF: 1687HTML: 4215Cover letter: 205Figure 1: 213 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2607PDF: 815HTML: 5231 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1174PDF: 488HTML: 329 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2048PDF: 774HTML: 3118 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1323PDF: 1023HTML: 125







